(Q35573294)

8 August 2017

1 reference

title

Common pathogenic mechanisms between depression and epilepsy: an experimental perspective (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

27 March 2024

author name string

Phillip C. Jobe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592636

27 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592636

27 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S152550500300221X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

https://api.elsevier.com/content/article/PII:S152550500300221X?httpAccept=text/plain

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

27 March 2024

1 reference

8 August 2017

volume

4 Suppl 3

1 reference

8 August 2017

page(s)

S14-24

1 reference

A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Are there specific anatomical and/or transmitter systems (cortical or subcortical) that should be targeted?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Depression and epilepsy: how closely related are they?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Penetrance and expressivity of genes involved in the development of epilepsy in the genetically epilepsy-prone rat (GEPR)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Animal models of limbic epilepsies: what can they tell us?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Angular bundle kindling is accelerated in rats with a genetic predisposition to acoustic stimulus-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

The expanding pharmacopoeia for bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

A review of randomized, controlled clinical trials in acute mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Antidepressants and seizures: clinical anecdotes overshadow neuroscience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effect of doxepin on seizure frequency in depressed epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effect of psychotropic medications on seizure control in patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Anticonvulsant effect of fluoxetine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Aggression, suicide, and serotonin: relationships to CSF amine metabolites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Serotonin concentrations and turnover in brains of depressed suicides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Decreased imipramine binding in the brains of patients with depressive illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Studies on the serotonin transporter in platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Polymorphism in serotonin transporter gene associated with susceptibility to major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

5-HT1D and 5-HT1E/1F binding sites in depressed suicides: increased 5-HT1D binding in globus pallidus but not cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Brain 5-HT1 binding sites in depressed suicides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

5-HT1A receptor responsivity in anxiety disorders and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Increased alpha 2-adrenoceptor density in the frontal cortex of depressed suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effect of clonidine on growth hormone release in psychiatric patients and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Putative neurotransmitter abnormalities in infantile spasms: cerebrospinal fluid neurochemistry and drug effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Cerebrospinal fluid monoamine metabolites in patients with infantile spasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Studies on CSF tryptophan metabolism in infantile spasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Reduction of biogenic amine levels in the Rett syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Changes in CSF neurotransmitters in infantile spasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Alpha-1 adrenoceptors are decreased in human epileptic foci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Biogenic amines in the human neocortex in patients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Abnormalities in 5-HT1A and 5-HT1B receptor binding in severe-seizure genetically epilepsy-prone rats (GEPR-9s)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Noradrenergic abnormalities in the genetically epilepsy-prone rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Treatment and outcome of Taiwanese patients with 6-pyruvoyltetrahydropterin synthase gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Depressive symptoms as relative and attributable risk factors for first-onset major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Critical review of data supporting affective disorder caused by nonpsychotropic medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Seizure inhibition by median raphe nucleus stimulation in rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effects of L-tryptophan, L-3, 4, dihydroxyphenylalanine and tranylcypromine on the electroencephalogram and on photically induced epilepsy in the baboon, Papio papio.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Behavioural and electrographic effects of L-5-hydroxytryptophan and D, L-parachlorophenyl-alanine on epileptic Senegalese baboon (Papio papio).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3s: a neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Letter: Effect of lithium carbonate and alpha-methyl-p-tyrosine on audiogenic seizure intensity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Carbamazepine-induced release of serotonin from rat hippocampus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Effect of repeated seizure experiences on tyrosine hydroxylase immunoreactivities in the brain of genetically epilepsy-prone rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Neuroendocrinology of stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Kainate receptors: subunits, synaptic localization and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Involvement of GABA in acoustically-evoked inhibition in inferior colliculus neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Role of GABA abnormalities in the inferior colliculus pathophysiology - audiogenic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Increased cortical GABA concentrations in depressed patients receiving ECT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of ?functional? psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

GABA function in mood disorders: an update and critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Regulation of striatal serotonin release by the lateral habenula-dorsal raphe pathway in the rat as demonstrated by in vivo microdialysis: role of excitatory amino acids and GABA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Regulation of serotonin release by GABA and excitatory amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Release-regulating GABAA receptors are present on noradrenergic nerve terminals in selective areas of the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Corticotropin-releasing hormone in depression and post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

New directions in the development of antidepressants: the interface of neurobiology and psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Association and linkage studies of CRH and PENK genes in bipolar disorder: a collaborative IGSLI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Differential release of corticotropin-releasing hormone (CRH) in the amygdala during different types of stressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Amygdala kindling of forebrain seizures and the occurrence of brainstem seizures in genetically epilepsy-prone rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Evidence of hypothyroidism in the genetically epilepsy-prone rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Fetal raphe transplants reduce seizure severity in serotonin-depleted GEPRs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Affective disorders in epilepsy

4

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

Depression in epilepsy: symptom or syndrome?

27 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

27 March 2024

sociology of the family

9

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

Scope and contribution of genetic models to an understanding of the epilepsies

27 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

27 March 2024

What is depression?

15

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

Tricyclic antidepressant-induced seizures and plasma drug concentration

27 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

Anticonvulsant drugs and the genetically epilepsy-prone rat

27 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence

27 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

The growth hormone response to clonidine in acute and remitted depressed male patients

27 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

Changes in CSF tryptophan metabolite levels in infantile spasms

27 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats

27 March 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

GABA receptor function and epilepsy

27 March 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.08.020

27 March 2024

Identifiers

1 reference

8 August 2017

1 reference